Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

HFRI Fund Weighted Composite Index up +2.43% in October (-3.5% YTD)

Tuesday, November 08, 2011

Kenneth J. Heinz
Opalesque Industry Update - Hedge funds posted the strongest monthly gains thus far in 2011, with the HFRI Fund Weighted Composite Index gaining +2.43 percent for October. The gain snaps a two-month decline and follows a 3Q drop of -6.5 percent, the fourth worst calendar quarter performance in history.

Equity Hedge strategies had the largest positive contribution to index performance in the month, with the HFRI Equity Hedge Index gaining +5.2 percent. This was the best single-month gain for Equity Hedge since May 2009 and snapped a volatile, 5-month decline for the strategy. Within Equity Hedge sub-strategies, the HFRI EH: Energy/Basic Materials rose +8.1 percent, while the HFRI EH: Technology/Healthcare Index gained +3.9 percent; the HFRI Emerging Markets Index gained +5.0%, partially reversing losses from the previous two months.

Event Driven funds also posted gains on improved equity markets, and tightening credit and M&A spreads, with the HFRI Event Driven Index up +2.7 percent, the best monthly gain in 2011, with positive contributions from Special Situations and Activist funds. Relative Value Arbitrage funds posted a gain of +1.33 percent, with gains in Corporate Fixed Income; for 2011, the HFRI Relative Value Index has gained +0.94 through October.

Macro funds posted declines on trend reversals, despite positive contributions from Commodity exposures and Discretionary managers. The HFRI Macro Index declined -1.4 percent in October, while the HFRI Macro: Systematic Diversified Index fell -3.5 percent, wiping out YTD gains with the worst month since July 2008.

"Hedge funds posted gains for October concentrated in Equity Hedge and Event Driven strategies, as managers adjusted exposures intra-month in response to rapidly improving condition across equity and credit markets," said Kenneth J. Heinz, President of HFR. "The primary focus for managers, as well as the primary catalyst for financial markets, continues to be the European sovereign debt crisis, with the outlook having improved despite the continued likelihood of volatility and unpredictable political developments. In the current environment, fund managers are looking to maintain tactical flexibility to opportunistically adjust exposure to dynamic market conditions, while maintaining core exposures to constructive portfolio themes across equity, credit, commodity and currency markets." Full press release: Source

(press release)

PD

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its